Answers are grounded in this paper and cite their sources.
Simplexides are natural glycolipids isolated from the marine sponge Plakortis simplex , and contain alkyl 4- O -(α-D-glucopyranosyl)-β-D-galactopyranoside. Simplexides can release of cytokines (IL-6) and chemokines (CXCL-8) from human monocytes and cause the expansion of natural killer T-cells (iNKTs) in vitro , with iNKTs contributing to the sustenance of immune homeostasis. Herein, the stereoselective syntheses of S -glycosidic analogues, i.e. S -simplexides, are described. The routes included Lewis acid promoted anomerisation of glycosyl thiols and thioglycolipids, as well as anomeric S -alkylation. Synthesis of O -glycosidic analogues are included. Heptadecanyl O - and S -glycosides as well as the 17-tritriacontyl 4- O -(α-D-glucopyranosyl)-β-D-galactopyranoside, a component of the natural simplexide isolate, all induced IL-6 and CXCL-8 production at both 10 and 30 μg/mL concentrations from PBMCs whereas the two S -simplexides were inactive. It is speculated that the lack of activity for the S -disaccharide analogue could be due to inhibition of cellular α-glucosidase, preventing degradation of the simplex disaccharide to a simpler galactopyranoside, whereas lack of activity for the S -galactolipid analogue could be due to increased conformational flexibility of S -glycosides. On the other hand, simpler unbranched O - and S -glycolipid analogues were active. Natural simplexide, and a synthetic simplexide, the 18-pentatriacontanyl 4- O -(α-D-glucopyranosyl)-β-D-galactopyranoside, were more potent than the new compounds tested.
No takes yet. Share an insight, caveat, or question.
Roux et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: